Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options

Gartrell Benjamin A.; Coleman Robert; Efstathiou Eleni; Fizazi Karim; Logothetis Christopher J.; Smith Matthew R.; Sonpavde Guru; Sartor Oliver; Saad Fred

首页> 外文期刊>European urology >Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options

【24h】

Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options

机译：转移性前列腺癌和骨癌的意义和治疗选择

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Context: Skeletal involvement is common in metastatic prostate cancer (PCa) and is associated with skeletal-related events (SREs). The interaction of PCa with the bone microenvironment contributes to self-perpetuating progression of cancer in bone. Bone-targeted agents (BTAs) are available for use in metastatic castration-resistant prostate cancer (mCRPC).

机译：背景：骨骼受累在转移性前列腺癌（PCa）中很常见，并且与骨骼相关事件（SRE）相关。 PCa与骨骼微环境的相互作用有助于骨骼中癌症的自我延续发展。骨靶向药物（BTA）可用于转移性去势抵抗性前列腺癌（mCRPC）。

著录项

来源
《European urology》 |2015年第5期|共9页
作者
Gartrell Benjamin A.; Coleman Robert; Efstathiou Eleni; Fizazi Karim; Logothetis Christopher J.; Smith Matthew R.; Sonpavde Guru; Sartor Oliver; Saad Fred;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Prostate cancer; Bone metastases; Bone-targeted agents; Skeletal-related events; Symptomatic skeletal events;

机译：前列腺癌;骨转移;骨靶向药物;骨骼相关事件;有症状的骨骼事件;
入库时间 2022-08-18 10:59:33

相似文献

外文文献
中文文献
专利

1. Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options [J] . Gartrell Benjamin A., Coleman Robert, Efstathiou Eleni, European urology . 2015,第5期

机译：转移性前列腺癌和骨癌的意义和治疗选择
2. Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era [J] . Tucci Marcello, Caffo Orazio, Buttigliero Consuelo, Cancer Treatment Reviews . 2019,第期

机译：一线转移性阉割前列腺癌的治疗选择：Chaarted和Latitude时代临床实践的建议
3. Lutetium-PSMA therapy-a new therapeutic option in metastatic castration-resistant prostate cancer? [J] . Michael Ladurner, Wolfgang Horninger, Jasmin Bektic Memo - Magazine of European medical oncology . 2018,第4期

机译：Lutetium-PSMA治疗 - 转移阉割抗阉割前列腺癌的新治疗选择？
4. Cryo and Laser Surgery as New Therapeutic Options in Patients with organ-confined Prostate Cancer who failed Radiotherapy [C] . Werner T.W. de Riese, Timothy J. Seipel, David. R. Aronoff, Conference on Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems Ⅻ Jan 19-20, 22, 2002 San Jose, USA . 2002

机译：冷冻和激光外科手术是放疗失败的器官受限型前列腺癌患者的新治疗选择
5. Inhibition of the alpha receptor for platelet-derived growth factor as a potential therapeutic in bone metastatic prostate cancer. [D] . Russell, Michael R. 2010

机译：抑制血小板衍生生长因子的α受体作为骨转移性前列腺癌的潜在治疗剂。
6. Enzalutamide (formerly MDV3100) as a new therapeutic option for men with metastatic castration-resistant prostate cancer [O] . Jeanny B Aragon-Ching 2012

机译：Enzalutamide（以前称为MDV3100）作为转移性去势抵抗性前列腺癌男性的新治疗选择
7. Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era [O] . Marcello Tucci, Orazio Caffo, Consuelo Buttigliero, 2019

机译：一线转移性阉割前列腺癌的治疗选择：Chaarted和Latitude时代临床实践的建议

Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options

摘要

著录项

相似文献

相关主题

期刊订阅